Literature DB >> 24686203

Neuroendocrine cancer. Closing the GAPP on predicting metastases.

Graeme Eisenhofer1, Arthur S Tischler2.   

Abstract

A promising grading system to predict metastasis in patients with phaeochromocytoma and paraganglioma assigns risk according to selected histological and other criteria. Such risk stratification might be useful for personalized management and screening programmes, as it could limit the costs of follow-up and reduce the risk of disseminated disease.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24686203     DOI： 10.1038/nrendo.2014.41

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


  10 in total

1.  Histological grading of adrenal and extra-adrenal pheochromocytomas and relationship to prognosis: a clinicopathological analysis of 116 adrenal pheochromocytomas and 30 extra-adrenal sympathetic paragangliomas including 38 malignant tumors.

Authors:  Noriko Kimura; Toshiya Watanabe; Takao Noshiro; Soichiro Shizawa; Yukio Miura
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

Review 2.  Pheochromocytomas and paragangliomas: assessment of malignant potential.

Authors:  Tim I M Korevaar; Ashley B Grossman
Journal:  Endocrine       Date:  2011-10-25       Impact factor: 3.633

3.  Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status.

Authors:  Graeme Eisenhofer; Jacques W M Lenders; Gabriele Siegert; Stefan R Bornstein; Peter Friberg; Dragana Milosevic; Massimo Mannelli; W Marston Linehan; Karen Adams; Henri J Timmers; Karel Pacak
Journal:  Eur J Cancer       Date:  2011-10-28       Impact factor: 9.162

Review 4.  Diagnostic tests and biomarkers for pheochromocytoma and extra-adrenal paraganglioma: from routine laboratory methods to disease stratification.

Authors:  Graeme Eisenhofer; Arthur S Tischler; Ronald R de Krijger
Journal:  Endocr Pathol       Date:  2012-03       Impact factor: 3.943

5.  Metastatic pheochromocytoma/paraganglioma related to primary tumor development in childhood or adolescence: significant link to SDHB mutations.

Authors:  Kathryn S King; Tamara Prodanov; Vitaly Kantorovich; Tito Fojo; Jacqueline K Hewitt; Margaret Zacharin; Robert Wesley; Maya Lodish; Margarita Raygada; Anne-Paule Gimenez-Roqueplo; Shana McCormack; Graeme Eisenhofer; Dragana Milosevic; Electron Kebebew; Constantine A Stratakis; Karel Pacak
Journal:  J Clin Oncol       Date:  2011-10-03       Impact factor: 44.544

6.  Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators.

Authors:  Montserrat Ayala-Ramirez; Lei Feng; Marcella M Johnson; Shamim Ejaz; Mouhammed Amir Habra; Thereasa Rich; Naifa Busaidy; Gilbert J Cote; Nancy Perrier; Alexandria Phan; Shreyaskumar Patel; Steven Waguespack; Camilo Jimenez
Journal:  J Clin Endocrinol Metab       Date:  2010-12-29       Impact factor: 5.958

7.  Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases.

Authors:  Lester D R Thompson
Journal:  Am J Surg Pathol       Date:  2002-05       Impact factor: 6.394

8.  Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma.

Authors:  Noriko Kimura; Ryoichi Takayanagi; Nae Takizawa; Eiji Itagaki; Takayuki Katabami; Narihiko Kakoi; Hiromi Rakugi; Yukihiro Ikeda; Akiyo Tanabe; Takeshi Nigawara; Sadayoshi Ito; Itaru Kimura; Mitsuhide Naruse
Journal:  Endocr Relat Cancer       Date:  2014-05-06       Impact factor: 5.678

9.  Observer variation in the application of the Pheochromocytoma of the Adrenal Gland Scaled Score.

Authors:  David Wu; Arthur S Tischler; Ricardo V Lloyd; Ronald A DeLellis; Ronald de Krijger; Francien van Nederveen; Vânia Nosé
Journal:  Am J Surg Pathol       Date:  2009-04       Impact factor: 6.394

10.  Protocol for the examination of specimens from patients with pheochromocytomas and extra-adrenal paragangliomas.

Authors:  Ozgur Mete; Arthur S Tischler; Ronald de Krijger; Anne Marie McNicol; Graeme Eisenhofer; Karel Pacak; Shereen Ezzat; Sylvia L Asa
Journal:  Arch Pathol Lab Med       Date:  2014-02       Impact factor: 5.534
  10 in total
  11 in total

1.  Continued Tumor Reduction of Metastatic Pheochromocytoma/Paraganglioma Harboring Succinate Dehydrogenase Subunit B Mutations with Cyclical Chemotherapy.

Authors:  Irfan Jawed; Margarita Velarde; Roland Därr; Katherine I Wolf; Karen Adams; Aradhana M Venkatesan; Sanjeeve Balasubramaniam; Marianne S Poruchynsky; James C Reynolds; Karel Pacak; Tito Fojo
Journal:  Cell Mol Neurobiol       Date:  2018-04-05       Impact factor: 5.046

Review 2.  New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification.

Authors:  Joakim Crona; David Taïeb; Karel Pacak
Journal:  Endocr Rev       Date:  2017-12-01       Impact factor: 19.871

3.  Malignancy in Pheochromocytoma or Paraganglioma: Integrative Analysis of 176 Cases in TCGA.

Authors:  Yong Joon Suh; Ji-Young Choe; Hyo Jin Park
Journal:  Endocr Pathol       Date:  2017-06       Impact factor: 3.943

4.  Urinary Bladder Paragangliomas: Analysis of Succinate Dehydrogenase and Outcome.

Authors:  Sounak Gupta; Jun Zhang; Michael Rivera; Lori A Erickson
Journal:  Endocr Pathol       Date:  2016-09       Impact factor: 3.943

Review 5.  The systems of metastatic potential prediction in pheochromocytoma and paraganglioma.

Authors:  Yong Wang; Minghao Li; Hao Deng; Yingxian Pang; Longfei Liu; Xiao Guan
Journal:  Am J Cancer Res       Date:  2020-03-01       Impact factor: 6.166

6.  Urinary Bladder Paragangliomas: How Immunohistochemistry Can Assist to Identify Patients With SDHB Germline and Somatic Mutations.

Authors:  Alessio Giubellino; Karlena Lara; Victoria Martucci; Than Huynh; Piyush Agarwal; Karel Pacak; Maria J Merino
Journal:  Am J Surg Pathol       Date:  2015-11       Impact factor: 6.394

Review 7.  Predictors of outcome in phaeochromocytomas and paragangliomas.

Authors:  Marlo Nicolas; Patricia Dahia
Journal:  F1000Res       Date:  2017-12-21

8.  Validation of pathological grading systems for predicting metastatic potential in pheochromocytoma and paraganglioma.

Authors:  Jung-Min Koh; Seong Hee Ahn; Hyeonmok Kim; Beom-Jun Kim; Tae-Yon Sung; Young Hoon Kim; Suck Joon Hong; Dong Eun Song; Seung Hun Lee
Journal:  PLoS One       Date:  2017-11-08       Impact factor: 3.240

9.  Over-diagnosis of potential malignant behavior in MEN 2A-associated pheochromocytomas using the PASS and GAPP algorithms.

Authors:  Adam Stenman; Jan Zedenius; Carl Christofer Juhlin
Journal:  Langenbecks Arch Surg       Date:  2018-05-19       Impact factor: 3.445

10.  Predicting Metastatic Potential in Pheochromocytoma and Paraganglioma: A Comparison of PASS and GAPP Scoring Systems.

Authors:  Heather Wachtel; Troy Hutchens; Ezra Baraban; Lauren E Schwartz; Kathleen Montone; Zubair Baloch; Virginia LiVolsi; Lauren Krumeich; Douglas L Fraker; Katherine L Nathanson; Debbie L Cohen; Lauren Fishbein
Journal:  J Clin Endocrinol Metab       Date:  2020-12-01       Impact factor: 5.958
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.